RhumbLine Advisers
ASTH icon

RhumbLine Advisers’s Astrana Health ASTH Stock Holding History

RhumbLine Advisers’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97M Buy
107,108
+6,494
+6% +$234K ﹤0.01% 1469
2026
Q1 		$2.47M Buy
100,614
+4,720
+5% +$112K ﹤0.01% 1748
2025
Q4 		$2.38M Sell
95,894
-1,448
-1% -$38.5K ﹤0.01% 1772
2025
Q3 		$2.76M Sell
97,342
-19,179
-16% -$520K ﹤0.01% 1731
2025
Q2 		$2.9M Buy
116,521
+1,714
+1% +$48.3K ﹤0.01% 1678
2025
Q1 		$3.56M Sell
114,807
-94
-0.1% -$3.13K ﹤0.01% 1526
2024
Q4 		$3.62M Sell
114,901
-1,049
-0.9% -$49.8K ﹤0.01% 1583
2024
Q3 		$6.72M Sell
115,950
-5,074
-4% -$249K 0.01% 1264
2024
Q2 		$4.91M Buy
121,024
+49
+0% +$1.94K ﹤0.01% 1415
2024
Q1 		$5.08M Buy
120,975
+1,007
+0.8% +$39.3K ﹤0.01% 1413
2023
Q4 		$4.59M Sell
119,968
-8,663
-7% -$288K ﹤0.01% 1473
2023
Q3 		$3.97M Buy
128,631
+3,565
+3% +$123K ﹤0.01% 1484
2023
Q2 		$3.95M Buy
125,066
+5,289
+4% +$181K ﹤0.01% 1524
2023
Q1 		$4.37M Buy
119,777
+5,421
+5% +$190K 0.01% 1407
2022
Q4 		$3.38M Buy
114,356
+8,801
+8% +$283K ﹤0.01% 1517
2022
Q3 		$4.12M Buy
105,555
+5,658
+6% +$259K 0.01% 1348
2022
Q2 		$3.85M Buy
99,897
+7,091
+8% +$270K 0.01% 1395
2022
Q1 		$4.5M Buy
92,806
+6,484
+8% +$334K 0.01% 1383
2021
Q4 		$6.34M Sell
86,322
-1,685
-2% -$138K 0.01% 1232
2021
Q3 		$8.01M Buy
88,007
+28,401
+48% +$2.42M 0.01% 1079
2021
Q2 		$3.74M Buy
59,606
+39,075
+190% +$1.44M ﹤0.01% 1599
2021
Q1 		$556K Sell
20,531
-1,345
-6% -$32.4K ﹤0.01% 2440
2020
Q4 		$400K Buy
21,876
+2,668
+14% +$48K ﹤0.01% 2530
2020
Q3 		$345K Buy
19,208
+1,254
+7% +$21.6K ﹤0.01% 2456
2020
Q2 		$296K Buy
17,954
+2,235
+14% +$35.2K ﹤0.01% 2584
2020
Q1 		$203K Sell
15,719
-301
-2% -$4.91K ﹤0.01% 2576
2019
Q4 		$295K Sell
16,020
-13,805
-46% -$229K ﹤0.01% 2597
2019
Q3 		$526K Buy
+29,825
New +$510K ﹤0.01% 2301
2018
Q3 		– Sell
-22,078
Closed -$571K – 2938
2018
Q2 		$571K Buy
+22,078
New +$378K ﹤0.01% 2244

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RhumbLine Advisers's ASTH Position: Q2 2026 in Review

RhumbLine Advisers increased its Astrana Health (ASTH) stake by 6.5% in Q2 2026, buying an estimated $234K and bringing the position to 107,108 shares worth $4.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

RhumbLine Advisers first reported a position in ASTH in Q2 2018 and has held it in 29 quarters since. The position peaked at $8.01M in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • RhumbLine Advisers held 107,108 shares of Astrana Health worth $4.97M as of Q2 2026.
  • RhumbLine Advisers bought 6,494 Astrana Health shares in Q2 2026, an estimated $234K.
  • Astrana Health made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1469 holding.
  • RhumbLine Advisers first reported a position in Astrana Health in Q2 2018 and has held it in 29 quarters since.
  • RhumbLine Advisers's Astrana Health position peaked at $8.01M in Q3 2021.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.